September 29, 2022
An international team of scientists, co-led by researchers at the University of California San Diego School of Medicine, has created the first pan-cancer mycobiome atlas—a survey of 35 types of cancer and their associated fungi.
May 10, 2018
…care at five different cancer centers hoping for a different outcome. At one center, he was treated with the only currently available therapy for metastatic basal cell carcinoma. It was ineffective. How to participate To learn more about the All of Us Research Program and how to join, please visit…
March 26, 2014
Napoleone Ferrara, MD, distinguished professor of pathology at the University of California, San Diego School of Medicine and senior deputy director for basic sciences at UC San Diego Moores Cancer Center, was named today among eight recipients of the Canada Gairdner Awards at a ceremony in Toronto.
November 30, 2018
A randomized clinical trial involving 97 medical centers in 20 countries, including Moores Cancer Center at UC San Diego Health, found that treating patients with head and neck cancer with the immunotherapy drug pembrolizumab is more effective and less toxic than standard chemotherapy.
October 26, 2021
University of California San Diego researchers describe how a pair of fundamental genetic and cellular processes — aneuploidy and unfolded protein response — are exploited by cancer cells to promote tumor survival and growth.
April 22, 2019
University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.
April 17, 2024
A University of California San Diego current graduate student in the Department of Theatre and Dance and an undergraduate alumna from the Department of Bioengineering are are among 30 recipients of the 2024 Paul & Daisy Soros Fellowship for New Americans.
July 23, 2020
Cancer Isn’t Taking a Timeout for COVID-19; Neither are Clinical Trials Before the COVID-19 pandemic, physician-scientists Drs. Ezra Cohen, Catriona Jamieson, Dan Kaufman and Stephen Schoenberger discussed one of 195 cancer therapeutic clinical trials available at UC San Diego Health. These life-saving studies continue to be offered. With additional safety…
February 19, 2020
UC San Diego bioengineers developed a control system that could make CAR T-cell therapy safer and more powerful when treating cancer. By programming CAR T cells to switch on when exposed to blue light, the researchers controlled the cells to destroy skin tumors in mice without harming healthy tissue
December 8, 2022
UC San Diego’s ranks now include 18 fellows of the National Academy of Inventors. Three professors have been named 2022 NAI fellows, the highest professional distinction awarded to academic inventors.
